Get the Stockscreener App
0.5796
2.66%
0.015
After Hours:
1.96
1.3804
+238.16%
Neuroone Medical Technologies Corp stock is traded at $0.5796, with a volume of 476.66K.
It is up +2.66% in the last 24 hours and down -46.33% over the past month.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
See More
Previous Close:
$0.5646
Open:
$0.5775
24h Volume:
476.66K
Relative Volume:
1.77
Market Cap:
$26.17M
Revenue:
$2.82M
Net Income/Loss:
$-13.47M
P/E Ratio:
-0.8524
EPS:
-0.68
Net Cash Flow:
$-13.61M
1W Performance:
+34.73%
1M Performance:
-46.33%
6M Performance:
-37.68%
1Y Performance:
-50.40%
1-Day Range:
$0.57
$0.61
1-Week Range:
$0.4429
$0.61
52-Week Range:
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Name
Neuroone Medical Technologies Corp
Sector
Industry
Phone
(952) 426-1383
Address
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.2623 | 398.00M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.21 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1717 | 347.36M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
JUNE
Dhandho Junoon Etf
|
11.11 | 204.17M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.91 | 131.34M | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-29-22 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Stock (NMTC) Latest News
NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus
Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com
NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com
NeuroOne Secures $11.3M in Fresh Capital, Forecasts Triple-Digit Growth - Stock Titan
NeuroOne Medical (NMTC) Gains Attention with Successful Pediatri - GuruFocus
Breakthrough: Teen Goes from 10 Seizures Per Night to Zero with New Brain Treatment - Stock Titan
Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock - Yahoo
NeuroOne Medical Technologies CEO buys $50,000 in common stock - Investing.com Australia
NeuroOne Medical Technologies CEO buys $50,000 in common stock By Investing.com - Investing.com South Africa
NeuroOne Medical’s CFO Ronald McClurg buys $100,000 in stock By Investing.com - Investing.com South Africa
NeuroOne Medical's CFO Ronald McClurg buys $100,000 in stock - Investing.com
NeuroOne Executives Make Significant Stock Purchases - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet - Benzinga
NeuroOne Announces Proposed Public Offering Of Common Stock To Raise Capital For Growth - Nasdaq
Neuroone stock hits 52-week low at $0.48 amid market challenges By Investing.com - Investing.com South Africa
Neuroone stock hits 52-week low at $0.48 amid market challenges - Investing.com
NeuroOne (NMTC) Announces $8 Million Public Offering - GuruFocus
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - Benzinga
NeuroOne Medical Technologies prices $8 million public offering of common stock - MSN
NeuroOne sets price for 16 million share offering - Investing.com
NeuroOne Raises $8M: Inside the Major Public Offering That's Catching Investor Attention - Stock Titan
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday - Benzinga
NeuroOne announces public offering of common stock - Investing.com
NeuroOne Medical Announces Strategic Stock Offering with Ladenburg Thalmann - Stock Titan
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock - Yahoo Finance
Fostering clinician-led biotech innovation - Medical Economics
Game-Changing Epilepsy Innovation: NeuroOne's FDA-Cleared Device Transforms Brain Treatment - StockTitan
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - Quantisnow
Breakthrough: First-Ever FDA-Cleared Device Transforms Epilepsy Treatment for 50M Patients - StockTitan
Tariffs and medical devices: What has the industry response been? - Medical Economics
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
NeuroOne speeds up FDA submission for nerve ablation system - Investing.com
NeuroOne Speeds Up FDA Timeline: Revolutionary Facial Pain Treatment Could Hit Market Earlier Than Expected - StockTitan
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Barchart
Can NeuroOne's Upcoming Investor Presentation Signal New Growth in Neurological Tech? - StockTitan
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Call Transcript - MSN
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge - MSN
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge By Investing.com - Investing.com Canada
NeuroOne Medical Technologies Corp Reports Q1 FY2025 Earnings: E - GuruFocus.com
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results - TradingView
Q1 Earnings Breakthrough: NeuroOne Hits Record $6.3M Revenue as Product Sales Triple - StockTitan
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. - EIN News
NeuroOne Medical Earnings Alert: Key Q1 2025 Results and Strategic Updates Coming February 12 - StockTitan
NeuroOne regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
NeuroOne regains Nasdaq compliance with share price - Investing.com
Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Inari Medical (NASDAQ:NARI) - Defense World
NeuroOne CEO shares company strategy in letter to shareholders - Investing.com
Neuroone Medical Technologies Corp Stock (NMTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuroone Medical Technologies Corp Stock (NMTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rosa David A | CEO and President |
Apr 04 '25 |
Buy |
0.50 |
100,000 |
50,000 |
1,161,289 |
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):